Mary Hatch, PhD

Dr. Hatch is an Associate Professor at the Addictions, Drug & Alcohol Institute (ADAI), Department of Psychiatry & Behavioral Sciences, UW School of Medicine. Her research interests are in the development and testing of behavioral and pharmacologic interventions for substance use disorders and HIV prevention. In particular, her work has focused on the intersection of substance use and HIV-related sex and drug risk behaviors from both the consumer and workforce perspectives, and on implementation factors that affect uptake of interventions. She has held multiple and varied roles in research projects since 1994, and has long-standing experience developing, implementing, and overseeing large-scale multi-site clinical trials with community treatment providers. In addition to her work at the University of Washington, Dr. Hatch is a licensed clinical psychologist at UWMC Outpatient Psychiatry Clinic. Her clinical work specializes in the treatment of drug and alcohol addictions and co-occurring depression, anxiety and trauma.


Psychology Fellow, Center for Excellence in Substance Abuse Treatment, VA Puget Sound Healthcare System-Seattle Division
Psychology Intern, VA Puget Sound Healthcare System-Seattle Division
PhD, Department of Psychology, University of Nebraska-Lincoln

Department Affiliations

Other Affiliations

NIDA Summer Research Internship Program

UW Medical Student Addiction Research Program (MedStAR)

Recent Publications

Autosomal Recessive Limb-Girdle Muscular Dystrophy-3: A Case Report of a Patient with Autism Spectrum Disorder.
(2023 Aug 5)
Genes (Basel) 14(8):
Lewis S, Woroch A, Hatch MK, Lozano R

A randomized clinical trial evaluating the impact of counselor training and patient feedback on substance use disorder patients' sexual risk behavior.
(2022 Sep)
J Subst Abuse Treat 140(): 108826
Hatch MA, Wells EA, Masters T, Beadnell B, Harwick R, Wright L, Peavy M, Ricardo-Bulis E, Wiest K, Shriver C, Baer JS

Sex Differences in Comorbid Mental and Substance Use Disorders Among Primary Care Patients With Opioid Use Disorder.
(2022 Dec 1)
Psychiatr Serv 73(12): 1330-1337
Braciszewski JM, Idu AE, Yarborough BJH, Stumbo SP, Bobb JF, Bradley KA, Rossom RC, Murphy MT, Binswanger IA, Campbell CI, Glass JE, Matson TE, Lapham GT, Loree AM, Barbosa-Leiker C, Hatch MA, Tsui JI, Arnsten JH, Stotts A, Horigian V, Hutcheson R, Bart G, Saxon AJ, Thakral M, Ling Grant D, Pflugeisen CM, Usaga I, Madziwa LT, Silva A, Boudreau DM

Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives.
(2021 May)
J Subst Abuse Treat 124(): 108223
Hatch-Maillette MA, Peavy KM, Tsui JI, Banta-Green CJ, Woolworth S, Grekin P

Dosage of booster phone calls following an SBIRT intervention in the emergency department for reducing substance use.
(2020 Sep)
J Subst Abuse Treat 116(): 108043
Hatch-Maillette MA, Donovan DM, Laschober TC

Show complete publication list »
Edit Profile